[Treatment of severe intermittent claudication: ORACLE-PGE1 short term study. A randomised 40-week study. Evaluation of efficacy and costs].

Abstract

BACKGROUND The efficacy and cost of prostaglandin E1 (PGE1) in severe intermittent claudication was studied comparing a long-term protocol (LTP) with a short-term protocol (STP) in a randomised 40-week study. METHODS Phase 1 was a 2-week run-in phase (no treatment) for both protocols. In LTP, phase 2 was the main treatment phase. Treatment was performed… (More)

Topics

Cite this paper

@article{Cesarone2002TreatmentOS, title={[Treatment of severe intermittent claudication: ORACLE-PGE1 short term study. A randomised 40-week study. Evaluation of efficacy and costs].}, author={Maria Rosaria Cesarone and Gianni V Belcaro and Andrew Nicolaides and Maura Griffin and George Geroulakos and Ganesh Ramaswami and Mich{\`e}le Cazaubon and Antonio B Barsotti and Spyros N. Vasdekis and Dimitrios C Christopoulos and Giovanni Battista Agus and Pietro Maria Bavera and P L Mondani and Edmondo Ippolito and Federica Flenda}, journal={Minerva cardioangiologica}, year={2002}, volume={50 6}, pages={683-90} }